Zomas A - Search Results

1

Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review.

Dalal M, Gupta J, Price K, Zomas A, Miao H, Ashaye A. Dalal M, et al. Among authors: zomas a. Expert Rev Hematol. 2020 Aug;13(8):907-922. doi: 10.1080/17474086.2020.1793666. Epub 2020 Aug 4. Expert Rev Hematol. 2020. PMID: 32749937

2

First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes.

Avigdor A, Trinchese F, Gavini F, Bent-Ennakhil N, Dalal M, Zomas A, Gettner Broun S, Gini G. Avigdor A, et al. Among authors: zomas a. EJHaem. 2022 Apr 19;3(2):415-425. doi: 10.1002/jha2.426. eCollection 2022 May. EJHaem. 2022. PMID: 35846037 Free PMC article.

3

Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries.

Assaf C, Waser N, Bagot M, He M, Li T, Dalal M, Gavini F, Trinchese F, Zomas A, Little M, Pimpinelli N, Ortiz-Romero PL, Illidge TM. Assaf C, et al. Among authors: zomas a. Cancers (Basel). 2021 Dec 29;14(1):145. doi: 10.3390/cancers14010145. Cancers (Basel). 2021. PMID: 35008309 Free PMC article.

4

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.

Terpos E, Ramasamy K, Maouche N, Minarik J, Ntanasis-Stathopoulos I, Katodritou E, Jenner MW, Plonkova H, Gavriatopoulou M, Vallance GD, Pika T, Kotsopoulou M, Kothari J, Jelinek T, Kastritis E, Aitchison R, Dimopoulos MA, Zomas A, Hajek R. Terpos E, et al. Among authors: zomas a. Ann Hematol. 2020 May;99(5):1049-1061. doi: 10.1007/s00277-020-03981-z. Epub 2020 Apr 1. Ann Hematol. 2020. PMID: 32236735 Clinical Trial.

5

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation.

Kaloyannidis P, Hertzberg M, Webb K, Zomas A, Schrover R, Hurst M, Jacob I, Nikoglou T, Connors JM. Kaloyannidis P, et al. Among authors: zomas a. Br J Haematol. 2020 Feb;188(4):540-549. doi: 10.1111/bjh.16201. Epub 2019 Oct 6. Br J Haematol. 2020. PMID: 31588564 Free PMC article.

6

Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.

Plattel WJ, Bergamasco A, Trinchese F, Gavini F, Bent-Ennakhil N, Zomas A, Castillon G, Arredondo-Bisono T, Cristarella T, Moride Y, von Tresckow B. Plattel WJ, et al. Among authors: zomas a. Leuk Lymphoma. 2021 Dec;62(14):3320-3332. doi: 10.1080/10428194.2021.1957865. Epub 2021 Jul 29. Leuk Lymphoma. 2021. PMID: 34323643

7

Primary renal lymphoma presenting with chronic low-grade fever.

Zomas A, Leivada A, Gortzolidis G, Michalis E, Skandalis A, Anagnostopoulos NI. Zomas A, et al. Int J Hematol. 2004 May;79(4):361-3. doi: 10.1532/ijh97.e0320. Int J Hematol. 2004. PMID: 15218966 Review.

8

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.

Dimopoulos MA, Tsatalas C, Zomas A, Hamilos G, Panayiotidis P, Margaritis D, Matsouka C, Economopoulos T, Anagnostopoulos N. Dimopoulos MA, et al. Among authors: zomas a. Semin Oncol. 2003 Apr;30(2):265-9. doi: 10.1053/sonc.2003.50079. Semin Oncol. 2003. PMID: 12720150 Review.

9

Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.

Dimopoulos MA, Hamilos G, Zomas A, Gika D, Efstathiou E, Grigoraki V, Poziopoulos C, Xilouri I, Zorzou MP, Anagnostopoulos N, Anagnostopoulos A. Dimopoulos MA, et al. Among authors: zomas a. Hematol J. 2004;5(2):112-7. doi: 10.1038/sj.thj.6200326. Hematol J. 2004. PMID: 15048060 Clinical Trial.

10

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

Dimopoulos MA, Anagnostopoulos A, Terpos E, Repoussis P, Zomas A, Katodritou E, Kyrtsonis MC, Delibasi S, Vassou A, Pouli A, Zervas K, Anagnostopoulos N, Maniatis A; Greek Myeloma Study Group. Dimopoulos MA, et al. Among authors: zomas a. Haematologica. 2006 Feb;91(2):252-4. Haematologica. 2006. PMID: 16461313 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters